Edition: Global  
One News Page
“Probably the fastest-access news portal in the world”
> >

Clovis Oncology Announces Exercise in Full of Underwriters’ Option to Purchase Additional Shares of Common Stock

Business Wire Thursday, 5 January 2017 ()
Clovis Oncology Announces Exercise in Full of Underwriters’ Option to Purchase Additional Shares of Common StockBOULDER, Colo.--(BUSINESS WIRE)--Clovis Oncology, Inc. (NASDAQ:CLVS) announced today that the underwriters of its recently announced public offering of its common stock have exercised in full their option to purchase an additional 750,000 shares. The offering, including the sale of the additional shares, is expected to close on January 9, 2017, subject to customary closing conditions. Clovis Oncology intends to use the net proceeds of the offering for general corporate purposes, including comme
0
shares
Share on
Facebook
Share on
Twitter
Post on 
Reddit
Share by
Email
 

You Might Like


Recent related news

Akers Biosciences Announces Closing of Public Offering

THOROFARE, NJ--(Marketwired - Jan 13, 2017) - Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR), (the "Company" or "Akers Bio"), a developer of rapid health...
Marketwired - Press ReleasesAlso reported by •Business WireGlobeNewswire

Takeda Commences Cash Tender Offer for All Outstanding Shares of ARIAD Pharmaceuticals, Inc.

Takeda Commences Cash Tender Offer for All Outstanding Shares of ARIAD Pharmaceuticals, Inc.
*Business Wire India*Takeda Pharmaceutical Company Limited (TOKYO:4502) (“Takeda”) announced the commencement of the cash tender offer by its wholly-owned...
Business Wire India - Press Releases

Omega Announces Eighteenth Consecutive Increase in Its Quarterly Common Stock Dividend

Omega Announces Eighteenth Consecutive Increase in Its Quarterly Common Stock Dividend
HUNT VALLEY, Md.--(BUSINESS WIRE)--Omega Healthcare Investors, Inc. (NYSE:OHI) today announced that the Company’s Board of Directors declared a common stock...
Business Wire - Press ReleasesAlso reported by •GlobeNewswire

Developer of cannabinoid patch seeking $50M from stock sale

Zynerba Pharmaceuticals Inc., which is developing synthetic cannabinoid treatments, is hoping to raise $50.4 million in a public stock offering. The Devon,...
bizjournals - Business


Other recent news in Press Releases

Glancy Prongay & Murray LLP Commences Investigation on Behalf of The WESTERN UNION Company InvestorsHodnett Cooper Real Estate Joins the BERKSHIRE HATHAWAY HomeServices Real Estate Brokerage Network
FOX News Channel Signs Former UK Independence Party Leader NIGEL FARAGE to Contributor RoleROCKWELL COLLINS Reports First Quarter Financial Results
RUSSIA Midstream Oil and Gas Industry Outlook to 2021: Market Forecasts for Liquefied Natural Gas (LNG), Oil Storage, Pipelines, Underground Gas Storage and Gas Processing - Research and MarketsIntex Enters Super Fight League with Team Gujarat WARRIORS
TOSHIBA Launches 800V Super Junction N-Channel Power MOSFETs for High Efficiency Power Supplies with Improved Low On-resistance and High Speed SwitchingMillennial Esports Corp.: New Year Sets Esports Stakes High in LAS VEGAS
GENERAL ELECTRIC Company: Doc re. GE files Form 8-KWill President DONALD TRUMP Take a Wrecking Ball to the TV Advertising Industry?

Twitter

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2017 One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter   FIND us on Google+